Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
Martoni A, Marino A, Sperandi F, Giaquinta S, Di Fabio F, Melotti B, Guaraldi M, Palomba G, Preti P, Petralia A, Artioli F, Picece V, Farris A, Mantovani L. Martoni A, et al. Among authors: melotti b. Eur J Cancer. 2005 Jan;41(1):81-92. doi: 10.1016/j.ejca.2004.08.029. Eur J Cancer. 2005. PMID: 15617993 Clinical Trial.
Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
Martoni AA, Melotti B, Sperandi F, Giaquinta S, Piana E, Pavesi L, Da Prada G, Lelli G. Martoni AA, et al. Among authors: melotti b. Lung Cancer. 2008 Jun;60(3):387-92. doi: 10.1016/j.lungcan.2007.11.006. Epub 2007 Dec 26. Lung Cancer. 2008. PMID: 18160123 Clinical Trial.
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
Barni S, Maiello E, Di Maio M, Ardizzoni A, Cappuzzo F, Maranzano E, Novello S, Bennati C, Ori A, Rizzoli S, Crinò L; RIGHT-3 study group. Barni S, et al. Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19. Lung Cancer. 2015. PMID: 26314614 Free article.
Sequential monitoring of pigmented lesions during dabrafenib treatment: a prospective study and a literature overview.
Dika E, Lambertini M, Fanti PA, Piraccini BM, Gurioli C, Ravaioli GM, Chessa MA, Traniello Gradassi A, Melotti B, Sperandi F, Patrizi A. Dika E, et al. Among authors: melotti b. G Ital Dermatol Venereol. 2019 Apr;154(2):170-176. doi: 10.23736/S0392-0488.17.05526-2. Epub 2017 Mar 14. G Ital Dermatol Venereol. 2019. PMID: 28290623 Free article. Clinical Trial.
91 results